Initial Statement of Beneficial Ownership (3)
December 29 2020 - 5:40PM
Edgar (US Regulatory)
FORM 3
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES
|
OMB APPROVAL
OMB Number:
3235-0104
Estimated average burden hours per response...
0.5
|
|
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
|
|
1. Name and Address of Reporting Person
*
Levinsohn Ross |
2. Date of Event Requiring Statement (MM/DD/YYYY)
8/26/2020
|
3. Issuer Name and Ticker or Trading Symbol
theMaven, Inc. [MVEN]
|
(Last)
(First)
(Middle)
225 LIBERTY STREET, 27TH FLOOR |
4. Relationship of Reporting Person(s) to Issuer (Check all applicable)
__X__ Director _____ 10% Owner ___X___ Officer (give title below) _____ Other (specify below) Chief Executive Officer / |
(Street)
NEW YORK, NY 10281
(City)
(State)
(Zip)
| 5. If Amendment, Date Original Filed(MM/DD/YYYY)
| 6. Individual or Joint/Group Filing(Check Applicable Line)
_X_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
|
Table I - Non-Derivative Securities Beneficially Owned
|
1.Title of Security (Instr. 4) | 2. Amount of Securities Beneficially Owned (Instr. 4) | 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) | 4. Nature of Indirect Beneficial Ownership (Instr. 5) |
Common Stock | 245434 | D | |
Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
|
1. Title of Derivate Security (Instr. 4) | 2. Date Exercisable and Expiration Date (MM/DD/YYYY) | 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) | 4. Conversion or Exercise Price of Derivative Security | 5. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 5) | 6. Nature of Indirect Beneficial Ownership (Instr. 5) |
Date Exercisable | Expiration Date | Title | Amount or Number of Shares |
Option to purchase | (1) | 4/10/2029 | Common Stock | 532004 | $0.46 | D | |
Option to purchase | (2) | 6/19/2029 | Common Stock | 2000000 | $0.42 | D | |
Option to purchase | (3) | 9/16/2029 | Common Stock | 2000000 | $0.81 | D | |
Explanation of Responses: |
(1) | The option shall be subject to vesting (i) based on the achievement by the Issuer of stock price and liquidity targets and (ii) a concurrent 36-month vesting period with a 12-month cliff. The ability to exercise is subject to both: i) vesting conditions (listed in the preceding sentence) and ii) the Issuer's Board of Directors approving a requisite increase in authorized shares of common stock, after the date the grant was issued, that would apply to this grant. |
(2) | 1/3 vest after 1 year. Balance vests monthly over next 2 years. Grant is pending an amendment to the Issuer's Certificate of Incorporation increasing the number of authorized shares of Common Stock to allow for exercise of the grant. |
(3) | 1/3 vest after 1 year. Balance vests monthly over next 2 years. Grant is pending an amendment to the Issuer's Certificate of Incorporation increasing the number of authorized shares of Common Stock to allow for exercise of the grant. |
Reporting Owners
|
Reporting Owner Name / Address | Relationships |
Director | 10% Owner | Officer | Other |
Levinsohn Ross 225 LIBERTY STREET, 27TH FLOOR NEW YORK, NY 10281 | X |
| Chief Executive Officer |
|
Signatures
|
/s/ Ross Levinsohn | | 12/29/2020 |
**Signature of Reporting Person | Date |